throbber
Expression of Secretory Mucin Genes by Human
`Conjunctival Epithelia
`
`Tsutomu Inatomi,* Sandra Spurr-Michaud,* Ann S. Tisdale,* Qian Zhan*
`Sandy T. Feldman,\ and Ilene K. Gipson*
`
`Purpose. To determine whether human conjunctival epithelium expresses any of the human
`mucin genes designated MUC2 through MUC7.
`Method. Northern blot analysis was performed using total RNA isolated from surgically re-
`moved conjunctival tissues. Complementary DNA or oligonucleotides to the tandem repeat
`region of each mucin gene were labeled and hybridized to conjunctival RNA. In situ hybridiza-
`tion also was performed to determine the distribution of mucin mRNA.
`
`Results. Only MUC4 and MUC5 probes hybridized to conjunctival RNA by Northern blot
`analysis. Both probes bound in a polydispersed pattern, which is characteristic of mucin genes.
`Using in situ hybridization, MUC4 mRNA was detected in the cells of the stratified conjunctival
`epithelium, whereas MUC5 mRNA expression was limited to goblet cells. MUC4 or MUC5
`probes did not hybridize to sections of corneal epithelium.
`
`Conclusions. The mucins MUC4 and MUC5 are expressed by the human conjunctiva. These
`mucins may play an important role in forming the tear-film layer at the air and ocular surface
`epithelium interface. Invest Ophthalmol Vis Sci. 1996;37:1684-1692.
`
`1 he surfaces of the corneal and conjunctival epithe-
`lia are covered by tear film, which has a variety of
`components, including mucus. Mucus constitutes the
`innermost layer of the tear film and interfaces with
`the apical surface of the epithelium. 1 This relationship
`of mucus to the apical surface of epithelium is present
`along all other mucosal surfaces, including those of
`the gastrointestinal, tracheobronchial, and reproduc-
`tive tracts. The most prominent components of the
`mucus layer are mucins. Mucins are glycoproteins in
`which at least 50% of mass is O-linked carbohydrate. 2
`Mucins are notoriously difficult glycoproteins to study;
`their high carbohydrate content impedes many con-
`ventional assays.
`Although the mucins are essential for the integrity
`of the tear film, in which they form a viscoelastic gel, 3
`the characteristics of mucins on the ocular surface
`are not well known. Several studies 4"7 have detailed
`
`From *Schepens Eye Research Institute and the Department of Ophthalmology,
`Harvard Medical School, Boston; and the "[Department of Ophthalmology,
`University of California, San Diego.
`Supported by National Institutes of Health research grant R37-EY03306 (IKG) and
`l/y The Massachusetts Lions Eye Research Fund.
`Submitted for publication October 18, 1995; revised February I, 1996; accepted
`March 7, 1996.
`Proprietary interest catebtny: N.
`Reprint requests: Ilene K. Cipson, Schepeiu Eye Research Institute, 20 Staniford
`Street, Boston, MA, 02114.
`
`1684
`
`approximate molecular weight, carbohydrate content,
`and amino acid composition of glycoproteins and
`plasma proteins of ocular mucus. These studies have
`provided the initial data suggesting the presence of a
`heterogeneous mixture of glycoproteins in the tear
`film.
`Generally, the mucins on the ocular surface have
`been considered to be derived from the goblet cells
`in the conjunctiva. Histologically, vesicles packed with
`periodic acid-Schiff or Alcian blue staining material
`can be detected inside the conjunctival goblet cells. 8
`These staining data suggest the presence of acidic and
`neutral carbohydrates in mucins. It has been proposed
`that the stratified squamous cells of the conjunctiva
`provide a second source of mucus for the tear film.' 110
`These cells were shown to contain vesicles that bind
`dyes with affinity for carbohydrate, and, by electron
`microscopy, the vesicles appeared to be emptying into
`the tear film. In support of that hypothesis, the con-
`junctival apical cell vesicles, as well as vesicles in apical
`cells of corneal epithelium, bind a monoclonal anti-
`body (H185) to mucin-like glycoproteins." Thus, con-
`junctival and corneal stratified squamous epithelia
`may provide a source of mucins for the ocular surface.
`A major advance in understanding mucin struc-
`ture, function, and heterogeneous character has come
`
`Investigative Ophthalmology & Visual Science, July 1996, Vol. 37, No. 8
`Copyright © Association for Research in Vision and Ophthalmology
`
`APOTEX 1021, pg. 1
`
`

`

`1685
`
`Chromosomal
`Mapping
`
`Amino Acids in
`Tandem Repeat
`
`References
`
`20
`23
`17
`16
`8
`29
`169
`23
`13/41
`
`15, 16
`18, 19
`24
`25
`19, 20
`21
`27
`23
`26
`
`Iq21q24
`Ilpl5
`
`73I
`
`lpl5
`Ilpl5
`Ilpl5
`. 4
`12
`
`Mucin Gene Expression in Conjunctiva
`
`TABLE l. Human Mucin Genes
`
`Designation
`
`Type if Sequence Verified
`
`cDNA Clone Source
`
`MUC1
`MUC2
`MUC3
`MUC4
`MUC5AC
`MUC5B
`MUC6
`MUC7
`MUC8
`
`Membrane-spanning
`Gel-forming-secretory
`
`Gel-forming-secretory
`
`Soluble monomer-secretory
`
`Mammary/pancreatic tumor
`Intestine
`Intestine
`Trachea
`Trachea
`Trachea
`Stomach
`Salivary gland
`Trachea
`
`from the recent cloning of mucin genes.2'12 M To date,
`nine human mucin genes have been cloned; they have
`been designated MUC1 through MUC8 (two MUC5
`genes have been described), in order of their discov-
`ery (Table 1). Besides the fact that the biochemical
`property of a high percentage of their mass (>50%)
`is O-linked oligosaccharides, each mucin gene pro-
`vides a unique amino acid sequence that is repeated
`tandemly in the protein backbone. The number and
`sequence of amino acids of each mucin tandem repeat
`unit is different for each mucin gene (Table I).1'1 The
`only common feature in the repetitive sequences are
`that they contain a high percentage of serine and/or
`threonine residues,1'1 which provide the O-glycosyla-
`tion sites on the protein. The number of amino acids
`in the tandem repeats of the eight mucin genes cloned
`to date varies from 8 to 169,M but the number of
`tandem repeats per mucin also can vary in individuals
`as a result of genetic polymorphism.1'
`Functionally, mucins have been subdivided into
`two types, transmembrane mucins and secretory mu-
`cins.2 Only one transmembrane mucin has been
`cloned. This mucin, MUC1, is found on the surfaces
`of various epithelial cells and carcinomas.15"' Re-
`cently, we reported17 that MUC1 mucin is expressed
`by corneal and conjunctival epithelial cells but not by
`goblet cells. We hypothesize that this transmembrane
`mucin plays a role in tear film spread and association
`of the mucus gel on the epithelial surface. Its anti-
`adhesion property may prevent adhesion of foreign
`debris to the ocular surface.
`Of the remaining mucins, MUC2 to MUC8, the
`best characterized are MUC2, MUC5, and MUC7.
`Complete cDNA sequence is available for MUC2 and
`MUC7. The MUC2 cDNA contains two tandem repeat
`domains and four cysteine-rich D domains that are
`homologous to von Willebrand factor.18 l9 These cys-
`teine-rich D domains appear to be necessary for the
`disulfide linking of mucin molecules, which leads to
`polymerization into gels. Initially, partial sequences of
`a number of MUC5 cDNAs were cloned.2021 They were
`placed into three groups, MUC5A, MUC5B, and
`MUC5C. All localize to chromosome Ilpl5. Recent
`
`data suggest that MUC5A and MUC5C are at precisely
`the same gene locus.22 Thus, MUC5A and MUC5C are
`part of the same gene and have been designated
`MUC5 or MUC5AC. MUC5B appears to be distinct
`from MUC5AC. Although the full length of MUC5
`cDNA is unknown, MUC5 has cysteine-rich regions
`with a high degree of homology to MUC2 cysteine-
`rich domains. The presence of this conserved domain
`of MUC5 suggests that MUC5, like MUC2, may be a
`gel-forming mucin. The second secretory mucin for
`which full-length cDNA sequence is known was cloned
`from the salivary gland and designated MUC7.2H In
`contrast to other larger secretory mucins, the full-
`length cDNA of MUC7 is 2350 bp. This small mucin,
`which exists as a monomer, lacks the cysteine-rich do-
`main found in MUC2 and MUC5.2:'
`The other mucin genes MUC3, MUC4, MUC6,
`and MUC8 are not as well characterized.1'1 MUC3 was
`cloned from a small intestine cDNA library and is ex-
`pressed in small intestine and colon.2'1 MUC4 and
`MUC8 were cloned from a tracheobronchial cDNA
`library; however, only tandem repeat sequences are
`available.2'21' Even though various tissues express
`MUC4, this mucin
`is relatively uncharacterized.
`MUC6, cloned from a stomach cDNA library, has the
`longest tandem repeat sequence reported.27
`It is unknown whether ocular surface epithelium
`expresses any of the cloned, so-called secretory mu-
`cins. To understand better the characteristics of the
`ocular surface mucins, we determined the expression
`of MUC2 through MUC7 by Northern blot analysis of
`conjunctival RNA and then, by in situ hybridization,
`determined the cellular origin of the expressed mu-
`cins.
`
`MATERIALS AND METHODS
`
`Tissue Samples
`
`All investigations followed the tenets of the Declara-
`tion of Helsinki, and informed consent and full institu-
`tional review board approval were obtained. Small seg-
`ments (approximately 1 x2 mm) of forniceal con-
`
`APOTEX 1021, pg. 2
`
`

`

`1686
`
`Investigative Ophthalmology & Visual Science, July 1996, Vol. 37, No. 8
`
`TABLE 2. Mucin cDNA and Oligonucleotide Probes Corresponding
`to Tandem Repeat Region
`
`Mucin Gene
`
`cDNA/oligo
`
`Designations
`
`Length (bp)
`
`References
`
`MUC2
`
`MUC3
`MUC4
`MUC5
`MUC6
`MUC7
`
`cDNA
`cDNA
`cDNA
`oligo
`cDNA
`cDNA
`oligo
`
`SMUC41
`HAM-1
`SIB124
`MUC4oligo
`4F
`MUC6.2T
`MUC7oligo
`
`836
`90
`387
`48
`494
`1014
`45
`
`bp = base pair; oligo = oligonucleotide; cDNA = complementary DNA.
`
`18
`32
`24
`25
`31
`27
`23
`
`junctiva were excised at the time of cataract surgery.
`All conjunctiva appeared normal at the time of preop-
`erative examination. None of the patients from whom
`samples were obtained were receiving chronic topical
`eye medications. Tissues for Northern blot analysis
`were frozen in liquid nitrogen immediately after re-
`moval and stored at — 70°C until RNA isolation. Four
`pieces of conjunctiva (three women and one man, 56
`to 77 years of age) were used to obtain sufficient RNA
`for analysis. Conjunctival tissues for in situ hybridiza-
`tion were fixed immediately after removal and pro-
`cessed as described below. Six samples were obtained;
`they included tissues from three women (70 to 75
`years of age) and three men (21, 67, and 70 years
`of age). Corneas with adjacent limbus and adjacent
`conjunctiva used for in situ hybridization were ob-
`tained from eye banks and were fixed less than 24
`hours after death.
`
`Isolation of RNA and Northern Blot Analysis
`Total RNA was isolated with an RNA Isolation Kit
`(Stratagene, La Jolla, CA) using an acid guanidinium
`thiocyanate phenol-chloroform
`single-step extrac-
`tion.28 Conjunctival RNA, isolated from two biopsies
`of forniceal conjunctiva, were pooled
`to obtain
`enough for one lane on each Northern blot. The pool-
`ing of several samples decreases the possibility of a
`false-negative result caused by tissue variation. Total
`RNA was isolated from cultured human corneal epi-
`thelium as described previously. 17 Total RNA from hu-
`man trachea, stomach, salivary gland, and small intes-
`tine, purchased from Clontech (Palo Alto, CA), were
`used for positive controls; a BT-20 breast carcinoma
`cell RNA, cultured rabbit corneal fibroblast RNA, and
`human umbilical vein endothelial cell RNA were used
`as negative controls.
`RNA samples of 10 (xg were separated on 1% aga-
`rose gels in the presence of formaldehyde. The integ-
`rity and amount of RNA loaded on each gel was deter-
`mined by staining with ethidium bromide. The RNA
`was then transferred to Gene Screen Plus membrane
`(DuPont, Boston, MA).
`The membranes were prehybridized in a solution
`
`of 50% formamide, 5 X saline-sodium phosphate-
`EDTA buffer, 5 X Denhardt's solution, 1% sodium
`dodecyl sulfate (SDS), 10% dextran sulfate, and 100
`//g/ml denatured salmon sperm DNA for 2 hours at
`42°C. Hybridization was performed in the same hy-
`bridization solution with 2 X 106 cpm/ml of 32P-la-
`beled probe at 42°C overnight. After hybridization,
`the membranes that were hybridized with cDNA
`probes were washed using high-stringency conditions;
`two washes with 2 X saline-sodium citrate (SSC) buffer
`for 15 minutes at room temperature, two washes with
`2 X SSC, 1% SDS at 55°C for 20 minutes, followed by
`two washes with 0.1 X SSC, 0.1% SDS at 55°C for 20
`minutes. For the oligonucleotide probes, high-strin-
`gency washes were decreased to 1 X SSC, 0.1% SDS
`at 42°C. After autoradiography, each membrane was
`stripped and reprobed three times.
`
`cDNA and Probe Preparation
`Because tandem repeat sequences are specific for
`each mucin gene 14 and probes corresponding to this
`region may hybridize to a number of the repeats of
`these sequences per mRNA, we chose to use cDNAs
`or oligonucleotides corresponding to tandem re-
`peat regions as probes for Northern blot analysis
`and in situ hybridization (Table 2). The sequence
`of cDNAs for MUC2, MUC3, and MUC5 were de-
`scribed in the references cited in Table 2. MUC6.2T
`cDNA clone contains two repeats of MUC6 tandem
`repeat sequence. Because cDNA probes for MUC4
`and MUC7 were unavailable, the most frequently
`found repetitive sequences of each tandem repeat
`were selected for oligonucleotide probes. MUC4
`oligo corresponds to antisense sequence of the 48-
`bp fragment of the 69-bp tandem repeat (5'-GTC-
`GGTGACAGGAAGAGGGGTGGCGTGACCTGT -
`GGATGCTGAGGAAGT-3'), and MUC7 oligo corre-
`sponds to the antisense sequence of a 45-bp tandem
`repeat ( 5' - GGTGTGGGTGGGGCAGCTGTGGTC-
`TCTGGTGGAGCTGAGGAAGAT-3'). These oligo-
`nucleotides, purified by reverse-phase chromatogra-
`phy, were purchased from BioServe (Laurel, MD)
`and labeled with y- 32P adenosine triphosphate by
`
`APOTEX 1021, pg. 3
`
`

`

`Mucin Gene Expression in Conjunctiva
`
`1687
`
`A
`
`12
`
`3
`
`4
`
`5 6 B 12
`
`3 4
`
`5 6
`
`12
`
`3 4 5 6
`
`5.5-
`
`2.8-
`
`1.9-
`1.G-
`
`2.8-
`
`1.9-
`1.6-
`
`7.4-
`5.5-
`
`2.8-
`
`1.9-
`1.6-
`
`7.4-
`
`1.9-
`1.6-
`
`2
`
`3
`
`5 6
`
`12
`
`3 4
`
`7.4-
`
`2.8-
`
`1.9-
`1,6-
`
`12
`
`3 4
`
`5
`
`28S
`
`18S
`
`H
`
`28S
`
`18S
`
`FIGUREI. Northern blot anal-
`ysis demonstrating tissue-spe-
`cific expression of mucin
`mRNA in conjunctiva and
`other tissues. RNA samples of
`10 fxg were separated on 1%
`agarose gels in the presence
`of formaldehyde. Two mem-
`branes, blots 1 and 2, were
`prepared, respectively. Blot 1
`was hybridized serially with
`probes for MUC2 (A), MUC4
`(C), and MUC6 (E), and blot
`2 was hybridized with probes
`for MUC3 (B), MUC5 (D),
`and MUC7
`(F). Ethidium
`bromide staining of each gel
`show the integrity of RNA
`blot 1 (G) and blot 2 (H).
`Note that probes for only
`MUC4 and MUC5 bound to
`the conjunctival RNA. RNA
`ladders were used as size
`markers: lane 1 = conjunc-
`tiva; lane 2 = stomach; lane
`3 = small intestine; lane 4 =
`trachea;
`lane 5 = salivary
`gland; lane 6 = human um-
`bilical vein endothelial cell
`HUVEC.
`
`T4 polynucleotide kinase (BioLabs, Richmond, CA).
`cDNA probes were labeled with a-:^P deoxycytidine
`triphosphate by Random Primer Plus kit (DuPont).
`Labeled probes were purified using a Sephadex-G25
`or Sephadex-G50 column (Boehringer-Mannheim,
`Indianapolis, IN) before Northern blot analysis.
`
`In Situ Hybridization
`Because MUC4 and MUC5 mRNA were detected in
`conjunctival RNA by Northern blot analysis, their dis-
`tribution was determined by in situ hybridization. Be-
`cause recent ARVO abstracts*1'™ suggest that MUC2
`is present at the ocular surface and because a faint
`band was detected for MUC7 by Northern blot analysis
`with extended exposure, in situ hybridization of
`MUC2 and MUC7 mRNA also was performed. Tech-
`
`niques were as previously described.17 Oligonucleo-
`tide probes to MUC4 and MUC7 were labeled with 3r>S-
`dATP by terminal deoxynucleotidyl transferase (Gibco
`BRL, Gaithersburg, MD). Antisense and sense ribo-
`probes, generated from the MUC5 cDNA (designated
`F4)3' and from the MUC2 cDNA (designated HAM-
`1),V2 were labeled with 35S-uridine triphosphate by T3
`or T7 RNA polymerase (Boehringer Mannheim, India-
`napolis, IN).
`Tissues prepared by two different methods were
`available. In one, frozen conjunctival sections were
`mounted on gelatin-coated slides and fixed with 4%
`paraformaldehyde. In the second, sections from 4%
`paraformaldehyde-nxed, paraffin-embedded
`tissues
`were mounted on gelatin-coated slides. Proteinase K
`treatment and acetylation were performed before hy-
`
`APOTEX 1021, pg. 4
`
`

`

`1688
`
`Investigative Ophthalmology & Visual Science, July 1996, Vol. 37, No. 8
`
`A
`
`12
`
`3 4 5
`
`1
`
`2
`
`3
`
`45
`
`
`
`u
`
`1
`
`2
`
`3 4
`
`5
`
`28S-
`
`18S
`
`7.4
`
`5.5
`
`2.8
`
`1.9
`1.6
`
`7.4-
`
`5.5-
`
`2.8-
`
`1.9-
`1.6-
`
`FIGURE 2. Northern blot anal-
`ysis demonstrated lack of ex-
`pression of MUC4 (A) and
`MUC5 (B) mRNA in cul-
`tured human corneal epithe-
`lium. RNA samples of 10 jig
`were separated on a 1% aga-
`rose gel in the presence of
`formaldehyde. Ethidium bro-
`mide staining shows the in-
`tegrity of RNA (C). Lane 1 =
`cultured human corneal epi-
`thelium; lane 2 = trachea;
`lane 3 = small intestine; lane
`4 = BT-20 breast cell carci-
`noma; lane 5 = cultured rab-
`bit corneal fibroblast.
`
`bridization. Hybridization was carried out in a solution
`of 50% formamide, 10% dextran sulfate, 0.3 M NaCl,
`1 X Denhardt's solution, 10 mM Tris, pH 8, 5 mM
`EDTA, 0.5 mg/ml tRNA, and 10 mM dithiothreitol.
`Sections were hybridized at 42°C for MUC4 and MUC7
`oligoprobes and at 57°C for MUC 2 and MUC5 ribo-
`probes. After washing, autoradiography was per-
`formed, and the sections were counterstained with
`hematoxylin and eosin. To verify the cellular distribu-
`tion of MUC4 mRNA, colorimetric, nonradioactive in
`situ hybridization was performed. MUC4 oligoprobes
`were labeled with digoxigenin (DIG)-dUTP (Boeh-
`ringer Mannheim) by
`terminal deoxynucleotidyl
`transferase. Sections were pretreated according to the
`protocol used with the 35S probe. MUC4 hybridization
`was performed at 37°C in a solution containing 50%
`formamide, 10% dextran sulfate, 20 //g/ml tRNA.
`After hybridization, washes were performed for 30
`minutes serially in each of the following: 2 X SSC at
`room temperature, 1 X SSC at room temperature, 0.5
`X SSC at 37°C, and 0.5 X SSC at room temperature.
`MUC4-hybridized probes were detected by DIG detec-
`tion kit (Boehringer Mannheim) according to the
`manufacturer's instruction.
`
`RESULTS
`
`Northern Blot Analysis
`To examine the expression of secretory mucin genes
`MUC2 through MUC7, Northern blot analysis (Fig. 1)
`was performed with probes to each MUC tandem re-
`peat region (Table 2). MUC2 and MUC3 mRNA were
`detected only in small intestine RNA and not in other
`RNA samples (Figs. 1A, IB). Positive signals of MUC2,
`MUC3, MUC4, MUC5, and MUC6 showed the typical
`smeared, polydispersed pattern previously reported as
`characteristic of these mucin genes. 18'24'25'27
`
`MUC4 mRNA expression was observed in con-
`junctiva as well as in trachea; the latter was used as
`positive control (Fig. 1C). Although the binding to
`conjunctiva is less intense than to trachea, both signals
`in conjunctiva and trachea show the typical polydis-
`persed pattern. In the MUC5 Northern blot (Fig. ID),
`an intense signal was detected in the positive controls
`of trachea and stomach, similar to that reported by
`Toribara et al. 27 The same polydispersed intense bind-
`ing was detected in conjunctiva (Fig. ID, lane 1).
`MUC6 mRNA expression was detected only in
`stomach RNA, as reported by Toribara et al.27 No bind-
`ing was observed in the conjunctival sample. Intense
`MUC7 mRNA signal, approximately 2.4 kbp, was de-
`tected in the salivary gland only (Fig. IF). A faint band
`of the same size appeared in conjunctiva only after an
`extended 4-day exposure of the autoradiogram (data
`not shown). The integrity and amount of RNA loaded
`on each gel was verified by staining with ethidium
`bromide, as shown in Figures 1G and 1H.
`To determine whether MUC4 or MUC5 mRNA ex-
`pression was limited to the conjunctival region of the
`ocular surface epidtelia, Northern blot analysis using
`total RNA from cultured human corneal epithelium,
`known to express MUC1,17 was performed. MUC4 and
`MUC5 probes bound to positive control RNA from tra-
`chea (Fig. 2, lanes A2 and B2) in the same fashion as
`shown in Figure 1C, lane 4, and Figure ID, lane 4. Figure
`2, lane A3, shows weak binding of MUC4 probe to small
`intestine RNA as previously reported14 and as shown in
`Figure 1C, lane 3. Neither MUC4 nor MUC5 mRNA was
`detected in cultured corneal epithelial RNA (Fig. 2). To
`verify these results, in situ hybridization was performed
`on corneal tissues (see next section).
`In Situ Hybridization
`The stratified conjunctival epithelium showed positive
`binding of the 35S-labeled MUC4 oligoprobe (Figs. 3A,
`
`APOTEX 1021, pg. 5
`
`

`

`Mucin Gene Expression in Conjunctiva
`
`1689
`
`FIGURE 3. MUC4 mRNA dis-
`tribution in conjunctiva us-
`ing in situ hybridization with
`HlS-labeled MUC4 antisense
`oligoprobe: (A) dark field;
`(B) bright
`field. MUC4
`mRNA distribution
`in con-
`junctiva using in situ hybrid-
`ization with MS-labeled MUC4
`sense oligoprobe: (C) dark
`field; (D) bright field. The
`conjunctival epithelium shows
`hybridization with
`the anti-
`sense probe. Goblet cells do
`not appear to be labeled pref-
`erentially {arrows, AJB). Digox-
`igenin-labeled probe (E, anti-
`sense probe; F, sense probe),
`which allows better resolution
`of cell borders, also demon-
`strated convincing hybridiza-
`tion of probes to the conjunc-
`tival epithelium, but hybridiza-
`tion to goblet cells was not
`obvious (arrows, E). In a sec-
`tion in which corneal, limbal,
`and conjunctival epithelium
`were present, hybridization of
`a'S probe,
`the
`indicating
`MUC4 mRNA expression, dis-
`appeared at die limbus (G).
`No expression was detected in
`either corneal (small arrow) or
`limbal
`(large arrow) epithe-
`lium. Bar = 50 //m (A to D);
`20 //m (E,F); 100 pm (G).
`
`\
`
`#
`* ,
`
`3B). The sense sequence of the same region of MUC4,
`used as a negative control probe, did not show any
`binding (Figs. 3C, 3D). To increase the resolution of
`the cellular distribution of MUC4 mRNA and to verify
`the tr'S data, DIG-labeled oligoprobe was used for in
`situ hybridization (Fig. 3E). The DIG data were consis-
`tent with the 35S results; the stratified conjunctival epi-
`thelium showed MUC4 mRNA expression; DIG-la-
`beled sense probe did not show any binding (Fig. 3F).
`Using tissue sections that included cornea and
`conjunctiva, expression of MUC4 mRNA in cornea
`was determined using MS-labeled MUC4 oligoprobe
`(Fig. 3G). MUC4 mRNA was detected in conjunctival
`epithelium. However, MUC4 mRNA expression disap-
`peared near the limbal region. No expression was ob-
`served in the corneal epithelium.
`Localization of MUC5 mRNA was determined
`
`with antisense riboprobe generated from the MUC5
`cDNA (Figs. 4A, 4B). Goblet cells showed intense sig-
`nal, but no signal was detected in the stratified epithe-
`lial cells. Some of the goblet cells did not show bind-
`ing. Sense probe transcribed from the MUC5 cDNA
`did not show any binding (Fig. 4C). Using tissue sec-
`tions that included cornea and conjunctiva, expres-
`sion of MUC5 mRNA in cornea also was determined.
`MUC5 mRNA was not detected in the corneal epithe-
`lium (Figs. 4D, 4E) of tissue sections in which goblet
`cells of the conjunctival epithelium were labeled with
`the MUC5 probe (Fig. 4F).
`MUC7 and MUC2 mRNA expression was exam-
`ined using in situ hybridization with MUC7 oligoprobe
`or HAM-1 riboprobe to MUC2, respectively. No MUC7
`binding was observed, even after an extensive 4-week
`exposure time (data not shown). No binding of MUC2
`
`APOTEX 1021, pg. 6
`
`

`

`1690
`
`A
`
`• . *
`
`Investigative Ophthalmology & Visual Science, July 1996, Vol. 37, No. 8
`
`FIGURE 4. MUC5 mRNA dis-
`tribution in conjunctiva us-
`ing in situ hybridization with
`35S-labeled MUC5 antisense
`riboprobe (A, low magnifica-
`tion), (B, high magnifica-
`tion), and sense riboprobe
`(C). Low magnification (A)
`shows overall pattern of in-
`tense signal in scattered cells.
`At high magnification (B),
`antisense probe bound to
`the goblet cells
`intensely
`(arrows). The control sense
`probe showed no binding
`over controls (C). In sections
`in which cornea, limbus, and
`conjunctiva were present,
`MUC5 mRNA was not de-
`tected in corneal epithelium
`(D, dark field; E, bright
`field), but conjunctival gob-
`let cells showed positive bind-
`ing (arrow, F), Bar =100 fim
`(A); 50 /jm (B toF).
`
`was observed in conjunctiva, whereas control sections
`of intestinal goblet cells showed intense binding (data
`not shown).
`
`DISCUSSION
`From the combined results of Northern blot analysis
`and in situ hybridization, we conclude that MUC4 and
`MUC5 mRNA are expressed in the human conjunc-
`tiva. Screening of MUC2 through MUC7 by Northern
`blot analysis showed a positive signal only with MUC4
`and MUC5. Further investigation by in situ hybridiza-
`tion demonstrated a different pattern of MUC4 and
`MUC5 mRNA distribution in conjunctival epithelium.
`The data suggest that the stratified epithelium, which
`expresses MUC4 mRNA, and the goblet cells, which
`express MUC5 mRNA, contribute to the production
`of ocular mucus. Recently, we reported17 the expres-
`sion of the transmembrane mucin, MUC1, by corneal
`and conjunctival stratified epithelia, but not goblet
`cells. To date, three of the cloned mucin genes are
`known to be expressed by the ocular surface epithe-
`lium and may contribute to the tear mucus layer. It
`is interesting tfiat each of these three mucins has a
`different pattern of mRNA expression in the ocular
`surface epithelium and that both classes of the cloned
`mucins (transmembrane and secretory mucins) are
`expressed.
`Expression of the secretory mucin MUC5 mRNA
`is limited to the goblet cells of the conjunctiva. On
`secretion, MUC5 may be the gel-forming mucin that
`provides the tear film mucus gel. The demonstrated
`
`presence of cysteine-rich domains in the MUC5 pro-
`tein backbone22 indicates that cross-links form be-
`tween individual MUC5 molecules by disulfide bonds,
`thus bringing about mucus gel formation.1'21'1 Some
`of the goblet cells at the conjunctival surface were not
`labeled with MUC5 probe. This result may reflect a
`difference in the differentiation stage of the labeled
`and unlabeled cells; perhaps the terminally differenti-
`ated goblet cells have translated all their MUC5
`mRNA. Studies of goblet cell-specific gene expression,
`such as that seen with MUC5, may provide further
`insight into the differentiation of goblet cells. Another
`possibility for lack of binding by some cells is that the
`goblet cell population may be heterogeneous. Some
`goblet cells may synthesize a different mucin than
`MUC5.
`The current study demonstrated convincing hy-
`bridization of MUC4 mRNA to conjunctival epithe-
`lium. MUC4 has been classified as a secretory mucin,14
`but, because only the tandem repeat sequence of
`MUC4 cDNA has been cloned,25 its detailed structure
`and function are still unclear. More cloning data are
`necessary for complete characterization as to whether
`MUC4 is truly a secretory type. Its designation as a
`secretory type mucin probably relates to its demon-
`strated expression by simple epithelia whose function
`is secretion. Expression of MUC4 mRNA by the stra-
`tified conjunctival epithelium is surprising because ex-
`pression of MUG4 had been demonstrated in only
`simple secretory-absorptive epithelia of bronchial, co-
`Ionic, and endocervical mucosa.33 It has been sug-
`gested that nongoblet cells of the conjunctiva provide
`
`APOTEX 1021, pg. 7
`
`

`

`Mucin Gene Expression in Conjunctiva
`
`a second source of mucin for the tear film. The sugges-
`tion was based on the presence of periodic acid-Schiff-
`positive vesicles inside the conjunctival epithelial cyto-
`plasm.'"0 Our data on the expression of MUC4 mRNA
`by nongoblet cell conjunctival epithelium is consistent
`with this suggestion. However, further research is re-
`quired to identify the contents of these secretory vesi-
`cles as MUC4.
`To determine whether MUC4 and MUC5 mRNA
`expression in the ocular surface is limited to the con-
`junctiva, Northern blot analysis was used to investigate
`the expression of these mucin mRNAs by cultured
`human corneal epithelium. Because it is difficult to
`obtain enough RNA for Northern blot analysis from
`in vivo human corneal epithelial samples, RNA from
`cultured human corneal epithelium, which produces
`MUC1 mRNA,17 was used. The results of these studies
`showed no expression of MUC4 or MUC5 mRNA by
`the cultured human corneal epithelium. In situ hy-
`bridization verified this result. Neither MUC4 nor
`MUC5 mRNA was detected in corneal epithelium in
`sections that had positive binding in the conjunctiva.
`It is noteworthy that expression of MUC4 mRNA
`ended near the limbal region. Thus, in the ocular
`surface epithelium, MUC4 and MUC5 may be specific
`to the conjunctiva.
`Two recent abstracts report use of antibodies de-
`scribed as 4F1 and 3A229 and an oligonucleotide probe
`to a region of the tandem repeat of MUC230 to assay
`for tear presence and human conjunctival expression,
`respectively. The abstracts report MUC2 in tears and
`MUC2 mRNA in conjunctival tissue. Using several
`methods, we could not corroborate the abstract data.
`As described above, in our hands, repeated Northern
`blot analysis using a cDNA probe (SMUC-41), which
`corresponds to an 836-bp region of several tandem
`repeats of the MUC2 molecule, did not show hybrid-
`ization to conjunctival mRNA but did show hybridiza-
`tion to small intestine mRNA. In addition, in situ hy-
`bridization using a 90-bp HAM-1 MUC2 probe to the
`tandem repeat region did not hybridize to conjuncti-
`val epithelium but did hybridize to small intestine. To
`extend these studies to tissues in which optimal RNA
`preservation was possible, in situ hybridization and
`Northern blot analysis using rat tissue and a 48-bp
`oligonucleotide probe to the tandem repeat of the rat
`MUC2 homologue34 were carried out. We could not
`detect MUC2 expression in rat conjunctiva by either
`method (unpublished data, 1995). One possible ex-
`planation for the discrepancy between our results and
`those of the two abstracts is tissue variation. Upregula-
`tion of MUC2 expression has been reported in in-
`flamed or hyperplastic respiratory tract epithelia.35 It
`would be interesting to determine whether a similar
`alteration of mucin expression occurs in the ocular
`surface in conditions of inflammation.
`Although integrity of RNA was confirmed by
`
`1691
`
`ethidium bromide staining before Northern blot anal-
`ysis, the positive signals of each mucin showed the
`typical polydispersed pattern. This polydispersity of
`mucin mRNA has been reported as a characteristic
`of mucin genes12 and has been discussed in several
`articles.1213 It may reflect the rapid turnover or insta-
`bility of mucin mRNA resulting from the extremely
`large size of mucin genes. Further investigation, how-
`ever, is required to clarify the reason for the polydis-
`persed pattern of mucin mRNA on Northern blots.
`The relationship between goblet cell density and
`mucus alteration in ocular surface disease has been
`well studied.36'37 It is obvious that the loss of goblet
`cells causes mucus deficiency. However, in some cases,
`decrease of tear breakup time does not correlate with
`the loss of goblet cells.38 Perhaps in some of these
`cases there is a deficiency in mucin production in
`the stratified conjunctival and corneal epithelia. The
`relationship between ocular disease and the alteration
`of MUC4, MUC5, or both, remains to be studied.
`In conclusion, we have demonstrated the expres-
`sion of MUC4 and MUC5 mucin mRNA in conjunc-
`tiva. These two mucins may play an important role in
`forming the gelled mucus layer at the air-ocular sur-
`face epithelium interface. This brings to three the
`number of cloned mucins expressed by the ocular
`surface epithelium, but their functions remain to be
`determined experimentally. It also remains to be de-
`termined whether the ocular surface expresses addi-
`tional uncharacterized or unique mucins.
`
`Key Words
`conjunctiva, gene expression, goblet cell, mucin (MUC)
`
`Acknowledgments
`
`The authors thank Dr. Neil Toribara for providing MUC2,
`MUC3, MUC5, and MUC6 cDNA, Dr. Carol Basbaum for
`HAM-1 cDNA, Dr. Enrico Cagliero for HUVEC mRNA, and
`Gale Unger for editorial assistance.
`
`References
`
`1. Nichols BA, Chiappino ML, Dawson CR. Demonstra-
`tion of the mucous layer of the tear film by electron
`microscopy. Invest Ophthalmol Vis Sri. 1985; 26:464-
`473.
`2. Strous GJ, Dekker J. Mucin-type glycoproteins. Crit Rev
`Biochem Mol Biol. 1992; 27:57-92.
`3. Holly F, Lemp M. Tear physiology and dry eyes. Surv
`Ophthalmol. 1977; 22:69-87.
`4. Iwata S, Kabasawa I. Fractionation and chemical prop-
`erties of tear mucoids. Exp Eye Res. 1971; 12:360-367.
`5. Moore JC, Tiffany JM. Human ocular mucus: Origins
`and preliminary characterisation. Exp Eye Res.
`1979; 29:291-301.
`6. Moore JC, Tiffany JM. Human ocular mucus: Chemi-
`cal studies. Exp Eye Res. 1981;33:203-212.
`7. Chao CC, Vergnes JP, Brown SI. Fractionation and
`partial characterization of macromolecular compo-
`
`APOTEX 1021, pg. 8
`
`

`

`1692
`
`Investigative Ophthalmology & Visual Science, July 1996, Vol. 37, No. 8
`
`nents from human ocular mucus. Exp

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket